期刊文献+

妊娠期高血压疾病血清中HGF、AngⅡ水平的变化及意义 被引量:1

Changes and significance of serum HGF,AngⅡ in hypertensive disorders in pregnancy
下载PDF
导出
摘要 目的检测妊娠期高血压疾病孕妇血清肝细胞生长因子(hepatocyte growth factor,HGF)、血管紧张素Ⅱ(AngⅡ)的水平,探讨二者变化的意义。方法采用双抗夹心酶联免疫吸附法(ELISA)测定72例妊娠期高血压疾病孕妇和23例正常妊娠孕妇血清HGF、AngⅡ水平。结果妊娠期高血压组[(145.7±17.2)pg/mL]、子痫前期组[(141.6±16.0)、(135.0±14.3)pg/mL]血清HGF水平较对照组[(211.6±20.8)pg/mL]降低(P<0.01);妊娠期高血压组[(97.5±11.0)ng/mL]、子痫前期组[(119.7±13.9)、(135.4±19.2)ng/mL]血清AngⅡ水平较对照组[(45.6±9.4)ng/mL]明显升高(P<0.01),妊娠期高血压组、轻度子痫前期、重度子痫前期血清AngⅡ水平逐次升高,组间比较差异有统计学意义(P<0.05)。结论妊娠期高血压疾病孕妇血清HGF水平降低,血清AngⅡ水平逐渐升高,提示二者可能参与了妊娠高血压疾病的发生和发展。 Objective To investigate the changes and values of serum HGF and Ang Ⅱ in hypertensive disorders in pregnancy. Methods Serum level of HGF and Ang Ⅱ were measured with enzyme linked immunosorbent assay (ELISA) in 72 cases of hypertensive disorders in pregnancy and 23 cases normal pregnant. Results Serum level of HGF were (145.7±17.2) pg/mL in gestational hypertension groups and [(141.6±16.0), (135.0±14.3) pg/mL] in pre-eclampsia groups, both of them were significant lower than (211.6±20.8) pg/mL of normal pregnant groups; Serum level of Ang Ⅱ in ges- tational hypertension were (97.5±11.0) ng/mL and [(119.7±13.9), (135.4±19.2) ng/mL] in preeclampsia, both of them were significant higher than (45.6±9.4) ng/mL of normal pregnant groups, and serum level of Ang Ⅱ were gradually increased in gestational hypertension, mild pre-eclampsia and severe pre-eclampsia groups, there were significant differences a- mong them (P 〈 0.05). Conclusion The changes of serum level of HGF and Ang H were concerned with the occur- rence and development of hypertensive disorders in pregnancy
作者 蔡大军
出处 《中国当代医药》 2013年第8期37-38,共2页 China Modern Medicine
  • 相关文献

参考文献8

二级参考文献61

  • 1崔蕴璞,韩彤妍,王新利,叶鸿瑁.血管紧张素转化酶基因插入/缺失多态性及β3肾上腺素能受体基因Trp64Arg多态性对胎儿宫内发育及新生儿胰岛素敏感性的影响[J].中华儿科杂志,2008,46(6):421-427. 被引量:3
  • 2林倩霞.妊娠期糖尿病合并妊娠高血压综合征相关因素的临床分析[J].临床和实验医学杂志,2006,5(4):337-338. 被引量:4
  • 3孙敬霞,王泽华,卢实.妊娠期高血压疾病肿瘤坏死因子-α及IL-6 IL-8在胎盘及血清中的表达及意义[J].中国实用妇科与产科杂志,2006,22(9):682-684. 被引量:21
  • 4Uehara Y, Mori C, Noda T, et al Rescue of embryonic lethality in hepatocyte growth factor/scatter factor knockout mice. Genesis, 2000, 27 (3) : 99
  • 5Dokras A, Gardner LM, Seflor EA, et al Regulation of human cytotrophoblast morphogenesis by hepatocyte growtfactor/scatter factor. Biology of Reproduction, 2001, 65 (4) : 1278
  • 6Polette M, Nawrocki B, Pintiaux A, et al Expressive of gelatinases A and B and their tissue inhibitors by ceils of early and term human placenta and gestational endometrium. Lab Invest, 1994, 71 (6) : 838
  • 7Dokras A, Gardner LM, Sefior EA et ol Regulation of human cytotrophoblast morphogenesis by hepatocyte growtfactor/scatter factor. Biology of Reproduction, 2001, 65 (4): 1278
  • 8Dash PR, Cartwright JE, Baker PN et al Nitric oxide protects human extravillous trophoblast cells from apoptosis by a cyclic GMP - dependent mechanism and independently of caspase 3 nitrosylation. Exp Cell Res, 2003, 287 (2): 314
  • 9Kauma SW, Bae -Jump V, Walsh SW. Hepatocyte growth factor stimulates trophoblast invasion: a potential mech - anism for abnormal placentation in preeclampsia in pree - clampsia. JClin Endocrin Metab, 1999, 84 (11): 4092
  • 10Darmochwal - Kolarz D, Leszczynska - Gorzelak B, Rolins - ki Jet al. The expression and concentrations of Fas/APO - 1 ( CD95 ) antigen in patients with severe pre - eclampasia. J Reprod Immunol, 2001, 49 (2) : 153

共引文献306

同被引文献11

引证文献1

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部